Siddharth Sitaram Sells 2,309 Shares of Doximity (NYSE:DOCS) Stock

Doximity, Inc. (NYSE:DOCS) insider Siddharth Sitaram sold 2,309 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the sale, the insider owned 89,396 shares in the company, valued at $2,303,734.92. This represents a 2.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Friday, April 10th, Siddharth Sitaram sold 2,427 shares of Doximity stock. The shares were sold at an average price of $21.09, for a total transaction of $51,185.43.
• On Tuesday, March 10th, Siddharth Sitaram sold 2,319 shares of Doximity stock. The shares were sold at an average price of $25.37, for a total transaction of $58,833.03.

Doximity Stock Down 23.3%

Shares of Doximity stock opened at $17.94 on Friday. The stock has a market cap of $3.31 billion, a price-to-earnings ratio of 18.12, a P/E/G ratio of 1.66 and a beta of 1.36. The firm has a 50 day moving average of $24.09. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $76.51.

Doximity declared that its Board of Directors has approved a stock buyback plan on Thursday, February 5th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent research reports. Bank of America reduced their price target on shares of Doximity from $56.00 to $47.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. Needham & Company LLC reduced their price target on shares of Doximity from $55.00 to $27.00 and set a “buy” rating for the company in a research report on Thursday. Royal Bank Of Canada reissued an “outperform” rating and set a $44.00 price target on shares of Doximity in a research report on Monday, March 9th. BMO Capital Markets reduced their price target on shares of Doximity from $25.00 to $20.00 and set a “market perform” rating for the company in a research report on Thursday. Finally, Jefferies Financial Group lowered shares of Doximity from a “buy” rating to a “hold” rating and reduced their price target for the stock from $51.00 to $19.00 in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and thirteen have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.62.

Institutional Investors Weigh In On Doximity

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Doximity by 59.5% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock worth $35,000 after purchasing an additional 179 shares during the period. Oregon Public Employees Retirement Fund grew its stake in shares of Doximity by 0.7% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 27,500 shares of the company’s stock worth $2,012,000 after purchasing an additional 200 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares during the period. Rakuten Securities Inc. grew its stake in shares of Doximity by 14.0% during the 3rd quarter. Rakuten Securities Inc. now owns 1,763 shares of the company’s stock worth $129,000 after purchasing an additional 217 shares during the period. Finally, BOKF NA grew its stake in shares of Doximity by 5.3% during the 3rd quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after purchasing an additional 269 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

More Doximity News

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity reported adjusted EPS of $0.26, ahead of one analyst estimate, and revenue rose 5.1% year over year to $145.37 million, showing the core business is still growing. Doximity Earnings Report
• Positive Sentiment: Commentary around AI adoption and customer growth suggests Doximity’s platform remains engaged with clinicians, which could support longer-term monetization. Zacks Coverage
• Neutral Sentiment: The company maintained strong profitability metrics, including a 23.84% return on equity and 37.54% net margin, but those figures were overshadowed by weaker near-term outlook commentary. Fiscal Q4 Earnings Snapshot
• Negative Sentiment: Doximity missed the broader analyst consensus on EPS, which disappointed traders looking for a stronger earnings beat. Doximity Lags Q4 Earnings Estimates
• Negative Sentiment: Most importantly, fiscal 2027 revenue guidance came in below Wall Street expectations, reinforcing concerns that growth is slowing while AI-related investment is pressuring margins. Doximity Q4 2026 Earnings Call Transcript
• Negative Sentiment: Multiple analysts cut price targets after the report, including JPMorgan, Truist, BMO Capital, Mizuho, and Needham, adding to the negative sentiment around the stock. Analyst Target Cuts
• Negative Sentiment: Unusual put-option buying and an insider share sale added to the cautious tone, even though the insider transaction was part of a pre-arranged trading plan. Insider Trade Disclosure

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.